These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 10843291
1. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P. Am J Surg Pathol; 2000 Jun; 24(6):870-6. PubMed ID: 10843291 [Abstract] [Full Text] [Related]
2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT. Cancer; 2001 Oct 25; 93(5):330-6. PubMed ID: 11668468 [Abstract] [Full Text] [Related]
3. [Three deceptive cases of intrahepatic metastases of colorectal origin with endobiliary growth, simulating cholangiocarcinoma. Importance of immunostaining of cytokeratin 7 and 20]. Rullier A, Le Bail B, Rullier E, Lamouliatte H, Saric J, Bioulac-Sage P. Ann Pathol; 1999 Mar 25; 19(1):33-6. PubMed ID: 10320910 [Abstract] [Full Text] [Related]
4. Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract. Cabibi D, Licata A, Barresi E, Craxì A, Aragona F. Pathol Res Pract; 2003 Mar 25; 199(2):65-70. PubMed ID: 12747467 [Abstract] [Full Text] [Related]
5. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis. Tot T, Samii S. APMIS; 2003 Dec 25; 111(12):1075-82. PubMed ID: 14678015 [Abstract] [Full Text] [Related]
6. Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma. Itatsu K, Fujii T, Sasaki M, Zen Y, Nakanuma Y. Hepatogastroenterology; 2007 Dec 25; 54(75):677-80. PubMed ID: 17591040 [Abstract] [Full Text] [Related]
7. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder. Duval JV, Savas L, Banner BF. Arch Pathol Lab Med; 2000 Aug 25; 124(8):1196-200. PubMed ID: 10923083 [Abstract] [Full Text] [Related]
8. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas. Tot T. Cancer; 2001 Nov 15; 92(10):2727-32. PubMed ID: 11745209 [Abstract] [Full Text] [Related]
9. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. Patsenker E, Wilkens L, Banz V, Osterreicher CH, Weimann R, Eisele S, Keogh A, Stroka D, Zimmermann A, Stickel F. J Hepatol; 2010 Mar 15; 52(3):362-9. PubMed ID: 20137822 [Abstract] [Full Text] [Related]
10. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Park SY, Kim HS, Hong EK, Kim WH. Hum Pathol; 2002 Nov 15; 33(11):1078-85. PubMed ID: 12454811 [Abstract] [Full Text] [Related]
11. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Tot T. Cancer; 1999 Jan 01; 85(1):171-7. PubMed ID: 9921990 [Abstract] [Full Text] [Related]
12. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma]. Zhao SM, Zhu XZ, Ji Y, Hou J. Zhonghua Bing Li Xue Za Zhi; 2008 Nov 01; 37(11):749-53. PubMed ID: 19094709 [Abstract] [Full Text] [Related]
13. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM, Lin DM, Lü N, Liu XY, Wen P, Liu FS. Zhonghua Yi Xue Za Zhi; 2003 Aug 10; 83(15):1350-2. PubMed ID: 12930693 [Abstract] [Full Text] [Related]
14. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases]. Fernandez C, Liprandi A, Bouvier-Labit C, Figarella-Branger D. Ann Pathol; 2001 Apr 10; 21(2):129-35. PubMed ID: 11373582 [Abstract] [Full Text] [Related]
15. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype. Tot T. Med Sci Monit; 2004 May 10; 10(5):BR139-43. PubMed ID: 15114262 [Abstract] [Full Text] [Related]
16. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Cai YC, Banner B, Glickman J, Odze RD. Hum Pathol; 2001 Oct 10; 32(10):1087-93. PubMed ID: 11679943 [Abstract] [Full Text] [Related]
17. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. Kennedy MT, Jordan RC, Berean KW, Perez-Ordoñez B. J Clin Pathol; 2004 Sep 10; 57(9):932-7. PubMed ID: 15333652 [Abstract] [Full Text] [Related]
18. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Dum D, Menz A, Völkel C, De Wispelaere N, Hinsch A, Gorbokon N, Lennartz M, Luebke AM, Hube-Magg C, Kluth M, Fraune C, Möller K, Bernreuther C, Lebok P, Clauditz TS, Jacobsen F, Sauter G, Uhlig R, Wilczak W, Steurer S, Minner S, Marx AH, Simon R, Burandt E, Krech T. Exp Mol Pathol; 2022 Jun 10; 126():104762. PubMed ID: 35390310 [Abstract] [Full Text] [Related]